Medication Development in Alcoholism: Investigating PPAR Agonists

NCT02158273 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Scripps Research Institute

Collaborators